𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial

✍ Scribed by S. Nair; A. M. Diehl; M. Wiseman; G. H. Farr Jr; R. P. Perrillo

Book ID
108603647
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
82 KB
Volume
20
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Metformin in the treatment of patients w
Metformin in the treatment of patients with non-alcoholic steatohepatitis
✍ A. Uygun; A. Kadayifci; A. T. Isik; T. Ozgurtas; S. Deveci; A. Tuzun; Z. Yesilov πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 77 KB

## Summary **Background** : Increased insulin resistance is the major pathogenic mechanism in the development of non‐alcoholic steatohepatitis. **Aim** : To investigate the therapeutic effect of metformin, a well‐known insulin‐sensitizing agent, in the treatment of non‐alcoholic steatohepatitis.

Rosiglitazone versus rosiglitazone and m
Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: A 12-month randomized, prospective, open- label trial
✍ Dawn M. Torres; Frances J. Jones; Janet C. Shaw; Christopher D. Williams; John A πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 393 KB

Medication combinations that improve the efficacy of thiazolidinediones or ameliorate weight-gain side effects of therapy represent an attractive potential treatment for (NASH). The aim of this randomized, open-label trial was to assess the efficacy of rosiglitazone and metformin in combination vers